Improved preservation of residual renal function in chronic hemodialysis patients using polysulfone dialyzers

American Journal of Kidney Diseases

Volumn 29, Issue 4, 1997, Pages 576-583

  McCarthy, James T ^a   Jenson, Bernice M ^a   Squillace, David P ^a   Williams, Amy W ^a  

^a MAYO CLINIC   (United States)

Author keywords

Biocompatibility; cellulose acetate; dialyzers; hemodialysis; intrinsic renal function; polysulfone; residual renal function

Indexed keywords

POLYSULFONE;

ADULT; AGED; ARTICLE; ARTIFICIAL KIDNEY; BIOCOMPATIBILITY; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMBRANE FILTER;

EID: 0030898153     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(97)90341-3     Document Type: Article

References (30)

1. Bonomini V, Feletti C, Vangelista A: Progression rate of residual renal function in conservative treatment and early dialysis. Int J Artif Organs 5:93-96, 1982
2. Lynn RI, Feinfeld DA: Importance of the residual renal function in end-stage renal disease. Semin Dial 2:1-3, 1989
3. Morduchowicz G, Winkler J, Zabludowski JR, Boner G: Effects of residual renal function in haemodialysis patients. Int Urol Nephrol 26:125-131, 1994
4. Ravid M, Lang R, Robson M: The importance of daily urine volume and residual renal function in patients treated by chronic hemodialysis. Dial Transplant 9:763-765, 1980
5. Feber J, Scharer K, Schaefer F, Mikova M, Janda J: Residual renal function in children on hemodialysis and peritoneal dialysis therapy. Pediatr Nephrol 8:579-583, 1994
6. Lutes R, Perlmutter J, Holley IL, Bernardini I, Piraino B: Loss of residual renal function in patients on peritoneal dialysis. Adv Perit Dial 9:165-168, 1993
7. Lysaght MJ, Vonesh EF, Gotch F, Ibels L, Keen M, Lindholm B, Nolph KD, Pollock CA, Prowant B, Farrell PC: The influence of dialysis treatment modality on the decline of remaining renal function. ASAIO Trans 37:598-604, 1991
8. Nolph KD: Is residual renal function better preserved with CAPD than with hemodialysis? AKF Nephrol Lett 7:1-4, 1990
9. Rottembourg J: Residual renal function and recovery of renal function in patients treated by CAPD. Kidney Int 43:S-106-S-110, 1993 (suppl 40)
10. Rottembourg J, Issad B, Gallego JL, Degoulet P, Aime F, Gueffaf DB, Legrain M: Evolution of residual renal function in patients undergoing maintenance haemodialysis or continuous ambulatory peritoneal dialysis. Proc EDTA 19:397-402, 1982
11. Hiroshige K, Yuu K, Takasugi M, Socjime M, Kuroiwa A: Residual renal function in patients on renal replacement therapies. J Am Soc Nephrol 5:416, 1994 (abstr)
12. Hakim RM, Wingard RL, Parker RA: Effect of the dialysis membrane in the treatment of patients with acute renal failure. N Engl J Med 331:1338-1342, 1994
13. Schiffl H, Lang SM, Konig A, Strasser T, Haider MC, Held E: Biocompatible membranes in acute renal failure: Prospective case-controlled study. Lancet 344:570-572, 1994
14. Hakim RM: Clinical implications of hemodialysis membrane biocompatibility. Kidney Int 44:484-494, 1993
15. Lazarus JM, Owen WF: Role of bioincompatibility in dialysis morbidity and mortality. Am J Kidney Dis 24:1019-1032, 1994
16. Schulman G: A review of the concept of biocompatibility. Kidney Int 43:S-209-S-212, 1993 (suppl 41)
17. Caramelo C, Alcazar R, Gallar P, Teruel JL, Velo M, Ortega O, Galera A, Da Silva M: Choice of dialysis membrane does not influence the outcome of residual renal function in haemodialysis patients. Nephrol Dial Transplant 9:675-677, 1994
18. Gung A, Schulman G, Hakim R: Hemodialysis membrane choice influences maintenance of residual renal function in an animal model. J Am Soc Nephrol 2:327, 1991 (abstr)
19. McCarthy JT: The use of polysulfone dialyzers slows the rate of intrinsic renal function loss in chronic hemodialysis patients. J Am Soc Nephrol 4:367, 1993 (abstr)
20. Albouze G, Yanai M, Calamai M, Testou D, Jungers P, Man NK: Urea rebound and residual renal function in the calculation of Kt/V and protein catabolic rate. Kidney Int 43:8-278-8-281, 1993 (suppl 41)
21. Iest CG, Vanholder RC, Ringoir SM: Loss of residual renal function in patients on regular haemodialysis. Int J Artif Organs 12:159-164, 1989
22. Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker L, Kusek JW, Striker G: The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. N Engl J Med 330:877-884, 1994
23. Roth D, Smith RD, Schulman G, Steinman TI, Hatch FE: Effects of recombinant human erythropoietin on renal function in chronic renal failure predialysis patients. Am J Kidney Dis 24:777-784, 1994
24. Zeller KR, Jacobson H: Reducing dietary protein intake to retard progression of diabetic nephropathy. Am J Kidney Dis 13:17-19, 1989
25. Cases A, Reverter JC, Escolar G, Sanz C, Lopez-Pedret J, Revert L, Ordinas A: Platelet activation on hemodialysis: Influence of dialysis membranes. Kidney Int 43:S-217-S-220, 1993 (suppl 41)
26. Falkenhagen D, Brown GS, Thomaneck U, Levin NW, Ivanovich P, Bergstrom J, Kishimoto T, Klinkmann H: Behaviour of white blood cells and the complement system. Nephrol Dial Transplant 8:8-14, 1993 (suppl 2)
27. Guttierrez A, Alvestrand A, Bergstrom J, Beving H, Lantz B, Henderson LW: Biocompatibility of hemodialysis membranes: A study in healthy subjects. Blood Purif 12:95-105, 1994
28. Levin NW, Zasuwa G: Relationship between dialyzer type and signs and symptoms. Nephrol Dial Transplant 8:30-39, 1993 (suppl 2)
29. McKenna RM, Macdonald C, Bernstein KN, Rush DN: Increased production of tumor necrosis factor activity by hemodialysis but not peritoneal dialysis patients. Nephron 67:190-196, 1994
30. Pertosa G, Tarantino EA, Gesualdo L, Montinaro V, Schena FP: C5b-9 generation and cytokine production in hemodialyzed patients. Kidney Int 43:8-221-8-225, 1993 (suppl 41)